Year |
Citation |
Score |
2023 |
Friedes C, Iocolano M, Ho Lee S, Duan L, Li B, Doucette A, Cohen RB, Aggarwal C, Sun LL, Levin WP, Cengel KA, Kao G, Kevin Teo BK, Langer CJ, Xiao Y, ... Bradley J, et al. The Effective Radiation Dose to Immune Cells Predicts Lymphopenia and Inferior Cancer Control in Locally Advanced NSCLC. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110030. PMID 38008414 DOI: 10.1016/j.radonc.2023.110030 |
0.337 |
|
2023 |
Yegya-Raman N, Ho Lee S, Friedes C, Wang X, Iocolano M, Kegelman TP, Duan L, Li B, Berlin E, Kim KN, Doucette A, Denduluri S, Levin WP, Cengel KA, Cohen RB, ... ... Bradley JD, et al. Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110005. PMID 37972736 DOI: 10.1016/j.radonc.2023.110005 |
0.316 |
|
2023 |
Weidhaas JB, Hu C, Komaki R, Masters GA, Blumenschein GR, Chang JY, Lu B, Dicker AP, Bogart JA, Garces YI, Narayan S, Robinson CG, Kavadi VS, Greenberger JS, Koprowski CD, ... ... Bradley J, et al. The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC. Cancer Research Communications. PMID 37728512 DOI: 10.1158/2767-9764.CRC-23-0084 |
0.308 |
|
2023 |
Yegya-Raman N, Berman AT, Ciunci CA, Friedes C, Berlin E, Iocolano M, Wang X, Lai C, Levin WP, Cengel KA, O'Reilly SE, Cohen RB, Aggarwal C, Marmarelis ME, Singh AP, ... ... Bradley JD, et al. Phase II trial of consolidation pembrolizumab after proton reirradiation for thoracic recurrences of non-small cell lung cancer: Pembro after PBT ReRT for NSCLC. International Journal of Radiation Oncology, Biology, Physics. PMID 37652303 DOI: 10.1016/j.ijrobp.2023.08.047 |
0.305 |
|
2023 |
Yegya-Raman N, Friedes C, Lee SH, Iocolano M, Duan L, Wang X, Li B, Aggarwal C, Cohen RB, Su W, Doucette A, Levin WP, Cengel KA, DiBardino D, Teo BK, ... ... Bradley JD, et al. Pneumonitis rates before and after adoption of immunotherapy consolidation in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiation. International Journal of Radiation Oncology, Biology, Physics. PMID 37619788 DOI: 10.1016/j.ijrobp.2023.08.039 |
0.359 |
|
2023 |
Lee SH, Geng H, Arnold J, Caruana R, Fan Y, Rosen MA, Apte AP, Deasy JO, Bradley JD, Xiao Y. Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617. International Journal of Radiation Oncology, Biology, Physics. PMID 37343707 DOI: 10.1016/j.ijrobp.2023.06.009 |
0.308 |
|
2023 |
Simone CB, Bradley J, Chen AB, Daly ME, Louie AV, Robinson CG, Videtic GMM, Rodrigues G. ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer. Practical Radiation Oncology. 13: 195-202. PMID 37080641 DOI: 10.1016/j.prro.2023.01.005 |
0.332 |
|
2023 |
Janopaul-Naylor JR, Cao Y, McCall NS, Switchenko JM, Tian S, Chen H, Stokes WA, Kesarwala AH, McDonald MW, Shelton JW, Bradley JD, Higgins KA. Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era. Frontiers in Oncology. 12: 1074675. PMID 36733369 DOI: 10.3389/fonc.2022.1074675 |
0.309 |
|
2023 |
Bogart J, Wang X, Masters G, Gao J, Komaki R, Gaspar LE, Heymach J, Bonner J, Kuzma C, Waqar S, Petty W, Stinchcombe TE, Bradley JD, Vokes E. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201359. PMID 36623230 DOI: 10.1200/JCO.22.01359 |
0.357 |
|
2022 |
McCall NS, Scott McGinnis H, Janopaul-Naylor JR, Kesarwala AH, Tian S, Stokes WA, Shelton JW, Steuer CE, Carlisle JW, Leal T, Ramalingam SS, Bradley JD, Higgins KA. Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 35870727 DOI: 10.1016/j.radonc.2022.07.015 |
0.355 |
|
2022 |
Contreras J, Srivastava A, Samson P, DeWees T, Govindan R, Baggstrom MQ, Morgensztern D, Roach M, Badiyan SN, Bradley J, Waqar S, Robinson C. Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 35074432 DOI: 10.1016/j.ijrobp.2022.01.012 |
0.355 |
|
2021 |
Jin JY, Hu C, Xiao Y, Zhang H, Paulus R, Ellsworth SG, Schild SE, Bogart JA, Dobelbower MC, Kavadi VS, Narayan S, Iyengar P, Robinson C, Greenberger JS, Koprowski C, ... ... Bradley JD, et al. Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617. Cancers. 13. PMID 34944813 DOI: 10.3390/cancers13246193 |
0.342 |
|
2021 |
Syed YA, Stokes W, Rupji M, Liu Y, Khullar O, Sebastian N, Higgins K, Bradley JD, Curran WJ, Ramalingam S, Taylor J, Sancheti M, Fernandez F, Moghanaki D. Surgical Outcomes for Early-Stage Non-Small Cell Lung Cancer at Facilities with Stereotactic Body Radiation Therapy Programs. Chest. PMID 34785235 DOI: 10.1016/j.chest.2021.11.004 |
0.327 |
|
2021 |
Skinner H, Hu C, Tsakiridis T, Santana-Davila R, Lu B, Erasmus JJ, Doemer AJ, Videtic GMM, Coster J, Yang AX, Lee RY, Werner-Wasik M, Schaner PE, McCormack SE, Esparaz BT, ... ... Bradley JD, et al. Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial. Jama Oncology. PMID 34323922 DOI: 10.1001/jamaoncol.2021.2318 |
0.304 |
|
2021 |
Gettinger SN, Redman MW, Bazhenova L, Hirsch FR, Mack PC, Schwartz LH, Bradley JD, Stinchcombe TE, Leighl NB, Ramalingam SS, Tavernier SS, Yu H, Unger JM, Minichiello K, Highleyman L, et al. Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 34264316 DOI: 10.1001/jamaoncol.2021.2209 |
0.312 |
|
2021 |
Qian D, Behera M, Carlisle J, Owonikoko T, Steuer C, Pakkala S, Kesarwala A, Fischer-Valuck B, Bradley J, Curran W, Ramalingam S, Higgins K. P76.05 Radiotherapy with Concurrent Versus Sequential Osimertinib for Advanced Non-Small Cell Lung Cancer: a Multi-Center Toxicity Analysis Journal of Thoracic Oncology. 16: S586-S587. DOI: 10.1016/J.JTHO.2021.01.1062 |
0.304 |
|
2020 |
Hassanzadeh C, Sita T, Savoor R, Samson PP, Bradley J, Gentile M, Roach M, Mohindra N, Waqar S, Kruser TJ, Robinson C. Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer. Journal of Thoracic Disease. 12: 6690-6700. PMID 33282370 DOI: 10.21037/jtd-20-1792 |
0.306 |
|
2020 |
Donington JS, Paulus R, Edelman MJ, Krasna MJ, Le QT, Suntharalingam M, Loo BW, Hu C, Bradley JD. Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. PMID 32798022 DOI: 10.1016/J.Jtcvs.2020.03.171 |
0.365 |
|
2020 |
Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, et al. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. International Journal of Radiation Oncology, Biology, Physics. 107: 631-640. PMID 32589990 DOI: 10.1016/J.Ijrobp.2020.05.012 |
0.309 |
|
2020 |
Fischer-Valuck BW, Robinson CG, Simone CB, Gomez DR, Bradley JD. Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer. Seminars in Radiation Oncology. 30: 223-231. PMID 32503787 DOI: 10.1016/j.semradonc.2020.02.001 |
0.362 |
|
2020 |
Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, ... ... Bradley J, et al. Modeling the impact of cardio-pulmonary irradiation on overall survival in NRG Oncology trial RTOG 0617. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32398326 DOI: 10.1158/1078-0432.Ccr-19-2627 |
0.51 |
|
2020 |
Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32342863 DOI: 10.1016/j.radonc.2020.04.001 |
0.309 |
|
2020 |
Nikitas J, Roach M, Robinson C, Bradley J, Huang J, Perkins S, Tsien C, Abraham C. Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Clinical and Translational Radiation Oncology. 21: 32-35. PMID 31956701 DOI: 10.1016/j.ctro.2019.12.001 |
0.347 |
|
2020 |
Ross HJ, Hu C, Higgins KA, Jabbour SK, Kozono DE, Owonikoko TK, Movsas B, Solberg T, Xiao C, Williams TM, Welsh JW, Simko J, Wang XF, Mohindra NA, Hsu C, ... ... Bradley J, et al. NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. Journal of Clinical Oncology. 38: TPS9082-TPS9082. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps9082 |
0.304 |
|
2020 |
Samson P, Roach M, Bradley J, Carpenter L, Kozower B, Meyers B, Puri V, Robinson C. Increased Rates of Serious Adverse Events among Stage I Non-small Cell Lung Cancer Surgical Patients who were Predicted to Receive Stereotactic Body Radiation Therapy by Treatment Allocation Modeling International Journal of Radiation Oncology*Biology*Physics. 108: e88. DOI: 10.1016/j.ijrobp.2020.07.1185 |
0.363 |
|
2020 |
Samson P, Perez M, Carpenter L, Roach M, Bradley J, Kozower B, Meyers B, Puri V, Robinson C. Comparing Prospective Quality of Life Assessments Among Clinical Stage I Non-Small Cell Lung Cancer Patients Receiving Surgery versus Stereotactic Body Radiation Therapy at One Year International Journal of Radiation Oncology*Biology*Physics. 108: e81-e82. DOI: 10.1016/j.ijrobp.2020.07.1170 |
0.315 |
|
2019 |
Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, Bogart JA, Forster KM, Magliocco AM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Koprowski CD, et al. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901162. PMID 31841363 DOI: 10.1200/Jco.19.01162 |
0.356 |
|
2019 |
Kennedy WR, Gabani P, Nikitas J, Robinson CG, Bradley JD, Roach MC. Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31481272 DOI: 10.1016/j.radonc.2019.08.010 |
0.311 |
|
2019 |
Das SK, McGurk R, Miften M, Sasa M, Bowsher J, Bayouth J, Erdi Y, Mawlawi O, Boellaard R, Bowen SR, Xing L, Bradley J, Schoder H, Yin FF, Sullivan DC, et al. Task Group 174 Report: Utilization of [ F]Fluorodeoxyglucose Positron Emission Tomography ([ F]FDG-PET) in Radiation Therapy. Medical Physics. PMID 31230358 DOI: 10.1002/Mp.13676 |
0.3 |
|
2019 |
Badiyan SN, Robinson CG, Bradley JD. Radiation Toxicity in Lung Cancer Patients: The Heart of the Problem? International Journal of Radiation Oncology, Biology, Physics. 104: 590-592. PMID 31162057 DOI: 10.1016/j.ijrobp.2019.03.007 |
0.321 |
|
2019 |
Gay HA, Santiago R, Gil B, Remedios C, Montes PJ, López-Araujo J, Chévere CM, Imbert WS, White J, Arthur DW, Horton JK, Jagsi R, Rabinovich R, Beriwal S, Viswanathan A, ... ... Bradley J, et al. Lessons Learned from Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients. Practical Radiation Oncology. PMID 30999000 DOI: 10.1016/J.Prro.2019.03.007 |
0.39 |
|
2019 |
Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, ... ... Bradley JD, et al. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800622. PMID 30943123 DOI: 10.1200/Jco.18.00622 |
0.343 |
|
2019 |
Kennedy WR, Gabani P, Nikitas J, Samson PP, Robinson CG, Bradley JD, Roach MC. Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy. Clinical and Translational Radiation Oncology. 16: 1-6. PMID 30859139 DOI: 10.1016/j.ctro.2019.02.004 |
0.311 |
|
2019 |
Ganti AK, Wang X, Stinchcombe TE, Wang Y, Bradley J, Cohen HJ, Kelly K, Paulus R, Ramalingam SS, Vokes EE, Pang H. Clinical prognostic model for older patients with advanced non-small cell lung cancer. Journal of Geriatric Oncology. PMID 30797707 DOI: 10.1016/J.Jgo.2019.02.007 |
0.419 |
|
2019 |
Lin AJ, Roach M, Bradley J, Robinson C. Combining stereotactic body radiation therapy with immunotherapy: current data and future directions. Translational Lung Cancer Research. 8: 107-115. PMID 30788240 DOI: 10.21037/Tlcr.2018.08.16 |
0.423 |
|
2019 |
Berman AT, Jabbour SK, Vachani A, Robinson C, Choi JI, Mohindra P, Rengan R, Bradley J, Simone CB. Empiric Radiotherapy for Lung Cancer Collaborative Group multi-institutional evidence-based guidelines for the use of empiric stereotactic body radiation therapy for non-small cell lung cancer without pathologic confirmation. Translational Lung Cancer Research. 8: 5-14. PMID 30788230 DOI: 10.21037/Tlcr.2018.12.12 |
0.466 |
|
2019 |
Park H, Johanns TM, Lockhart AC, Bradley J, Roach M, Vlacich G, Amin M, Suresh R, Bagegni N, Robinson CG. Abstract CT212: Combining pembrolizumab with locally delivered radiation therapy for the treatment of metastatic esophageal cancer Clinical Trials. DOI: 10.1158/1538-7445.Sabcs18-Ct212 |
0.391 |
|
2019 |
Bazhenova L, Redman M, Gettinger S, Hirsch FR, Mack P, Schwartz L, Gandara D, Bradley J, Stinchcombe T, Leighl N, Ramalingam S, Tavernier S, Minichiello K, Kelly K, Papadimitrakopoulou V, et al. OA04.01 A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Cell Lung Cancer Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.423 |
0.382 |
|
2019 |
Samson P, Roach M, Carpenter L, Bradley J, Kozower B, Puri V, Meyers B, Robinson C. Algorithm Assignment to Stereotactic Body Radiation Therapy Is Associated with High Risk of Post-Surgical Serious Adverse Events in Stage I Non-small Cell Lung Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 105: E530-E531. DOI: 10.1016/j.ijrobp.2019.06.2436 |
0.325 |
|
2019 |
Lin A, Srivastava A, Contreras J, Campian J, Badiyan S, Roach M, Bradley J, Robinson C. Lymphocyte-Sparing with Hypofractionated Proton Radiation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) International Journal of Radiation Oncology*Biology*Physics. 105: E517. DOI: 10.1016/j.ijrobp.2019.06.1355 |
0.342 |
|
2019 |
Samson P, Robinson C, Kennedy W, Gabani P, Roach M, Bradley J, Kozower B, Puri V, Meyers B. Treatment Allocation Modeling and Risk-Stratified Outcomes for Clinical Stage I Non-small Cell Lung Cancer Patients Receiving Surgery versus Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 104: 235. DOI: 10.1016/J.IJROBP.2019.01.023 |
0.36 |
|
2018 |
Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, ... ... Bradley JD, et al. Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 30513377 DOI: 10.1016/J.Ijrobp.2018.11.051 |
0.324 |
|
2018 |
Nikitas J, DeWees T, Rehman S, Abraham C, Bradley J, Robinson C, Roach M. Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers. Clinical Lung Cancer. PMID 30477740 DOI: 10.1016/J.Cllc.2018.10.010 |
0.412 |
|
2018 |
Schild SE, Fan W, Stinchcombe TE, Vokes EE, Ramalingam SS, Bradley JD, Kelly K, Pang HH, Wang X. Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30292852 DOI: 10.1016/j.jtho.2018.09.021 |
0.344 |
|
2018 |
Roach MC, Bradley JD, Robinson CG. Optimizing radiation dose and fractionation for the definitive treatment of locally advanced non-small cell lung cancer. Journal of Thoracic Disease. 10: S2465-S2473. PMID 30206492 DOI: 10.21037/jtd.2018.01.153 |
0.377 |
|
2018 |
Roach MC, Robinson CG, DeWees TA, Ganachaud J, Przybysz D, Drzymala R, Rehman S, Kashani R, Bradley JD. Stereotactic body radiation therapy (SBRT) for central early stage non-small cell lung cancer: results of a prospective phase I/II trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30056162 DOI: 10.1016/J.Jtho.2018.07.017 |
0.33 |
|
2018 |
Samson P, Rehman S, Juloori A, DeWees T, Roach M, Bradley J, Videtic GMM, Stephans K, Robinson C. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule. Practical Radiation Oncology. PMID 29907514 DOI: 10.1016/J.Prro.2018.04.004 |
0.479 |
|
2018 |
Contreras JA, Lin AJ, Weiner A, Speirs C, Samson P, Mullen D, Campian J, Bradley J, Roach M, Robinson C. Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29859754 DOI: 10.1016/J.Radonc.2018.05.017 |
0.444 |
|
2018 |
Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW, Bradley JD, Choy H. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. Jama Oncology. PMID 29852037 DOI: 10.1001/Jamaoncol.2018.1251 |
0.322 |
|
2018 |
Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, Choy H. Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer. Jama Oncology. PMID 29852036 DOI: 10.1001/jamaoncol.2018.1258 |
0.302 |
|
2018 |
Liao Z, Gandhi SJ, Lin SH, Bradley J. Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors? Seminars in Radiation Oncology. 28: 114-124. PMID 29735187 DOI: 10.1016/J.Semradonc.2017.11.002 |
0.383 |
|
2018 |
Schild SE, Fan W, Stinchcombe TE, Vokes EE, Ramalingam SS, Bradley JD, Kelly K, Pang HH, Wang X. Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29689435 DOI: 10.1016/j.jtho.2018.04.011 |
0.354 |
|
2018 |
Waqar SN, Samson PP, Robinson CG, Bradley J, Devarakonda S, Du L, Govindan R, Gao F, Puri V, Morgensztern D. Non-small-cell Lung Cancer With Brain Metastasis at Presentation. Clinical Lung Cancer. PMID 29526531 DOI: 10.1016/J.Cllc.2018.01.007 |
0.388 |
|
2018 |
Roach MC, Robinson CG, Bradley JD. Natural Disasters and the Importance of Minimizing Subsequent Radiation Therapy Interruptions for Locally Advanced Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 100: 836-837. PMID 29485056 DOI: 10.1016/j.ijrobp.2017.11.001 |
0.341 |
|
2018 |
Schild S, Fan W, Stinchcombe T, Vokes E, Ramalingam S, Bradley J, Kelly K, Pang H, Wang X. OC-0492: A pooled analysis of radiotherapy dose & targeting strategies for stage 3 non-small cell lung cancer Radiotherapy and Oncology. 127: S253. DOI: 10.1016/s0167-8140(18)30802-8 |
0.325 |
|
2018 |
Samson P, Roach M, Bradley J, Carpenter L, Kozower B, Meyers B, Puri V, Robinson C. Comprehensive Baseline Clinical Assessments in Stage I Non-Small Cell Lung Cancer Patients May Facilitate Treatment Allocation Between Stereotactic Body Radiation Therapy and Surgery International Journal of Radiation Oncology*Biology*Physics. 102: S233. DOI: 10.1016/j.ijrobp.2018.07.170 |
0.347 |
|
2018 |
Goldstein M, Fischer-Valuck B, Samson P, Robinson C, Bradley J, Abraham C. Trends in Regimen for Palliative Radiation Therapy of Bone Metastases in Patients with Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e440-e441. DOI: 10.1016/J.IJROBP.2018.07.1278 |
0.32 |
|
2018 |
Juloori A, Zajichek A, Kattan M, Mullen D, Samson P, Woody N, Roach M, Bradley J, Videtic G, Robinson C, Stephans K. An Externally Validated Nomogram for Predicting Distant Metastasis after Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Implications for Adjuvant Systemic Therapy International Journal of Radiation Oncology*Biology*Physics. 102: S11. DOI: 10.1016/j.ijrobp.2018.06.120 |
0.319 |
|
2018 |
Contreras J, Lin A, Weiner A, Speirs C, Mullen D, Bradley J, Roach M, Robinson C. (P37) Radiation-Induced Immunosuppression in Locally Advanced Non-Small Cell Lung Cancer: Another Cardiac Toxicity? International Journal of Radiation Oncology Biology Physics. 101. DOI: 10.1016/J.Ijrobp.2018.02.125 |
0.434 |
|
2018 |
Samson P, Pérez M, Roach M, Bradley J, Frederiksen C, Carpenter L, Mullen D, Kozower B, Meyers B, Broderick S, Puri V, Robinson C. (OA01) Prospective Baseline Quality of Life in Clinical Stage I Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiation Therapy Versus Surgery: The Starting Line Is not the Same International Journal of Radiation Oncology Biology Physics. 101. DOI: 10.1016/J.Ijrobp.2018.02.040 |
0.419 |
|
2017 |
Henke L, Kashani R, Robinson C, Curcuru A, DeWees T, Bradley J, Green O, Michalski J, Mutic S, Parikh P, Olsen J. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29277446 DOI: 10.1016/J.Radonc.2017.11.032 |
0.35 |
|
2017 |
Higgins KA, Pillai RN, Chen Z, Tian S, Zhang C, Patel P, Pakkala S, Shelton J, Force SD, Fernandez FG, Steuer CE, Owonikoko TK, Ramalingam SS, Bradley JD, Curran WJ. Concomitant chemotherapy and radiotherapy with SBRT Boost for Unresectable, Stage III Non-small Cell Lung Cancer: A phase I Study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28919394 DOI: 10.1016/J.Jtho.2017.07.036 |
0.366 |
|
2017 |
Huang EX, Robinson CG, Molotievschi A, Bradley JD, Deasy JO, Oh JH. Independent test of a model to predict severe acute esophagitis. Advances in Radiation Oncology. 2: 37-43. PMID 28740914 DOI: 10.1016/J.Adro.2016.11.003 |
0.434 |
|
2017 |
Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, ... Bradley JD, et al. Randomized Phase II Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-small Cell Lung Cancer: NRG Oncology RTOG 0839. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28629896 DOI: 10.1016/J.Jtho.2017.06.007 |
0.318 |
|
2017 |
Jeong J, Oh JH, Sonke JJ, Belderbos JSA, Bradley JD, Fontanella AN, Rao SS, Deasy J. Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28539466 DOI: 10.1158/1078-0432.Ccr-16-3277 |
0.519 |
|
2017 |
Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, ... ... Bradley JD, et al. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 35: 56-62. PMID 28034064 DOI: 10.1200/Jco.2016.69.1378 |
0.357 |
|
2017 |
Oh JH, Apte A, Al-Lozi R, Bradley J, Naqa IME. Towards Prediction of Radiation Pneumonitis Arising from Lung Cancer Patients Using Machine Learning Approaches Journal of Radiation Oncology. 1: 30-43. DOI: 10.5166/Jroi-1-1-5 |
0.421 |
|
2017 |
Ganti A, Wang X, Stinchcombe T, Wang Y, Kelly K, Paulus R, Bradley J, Ramalingam S, Cohen H, Vokes E, Pang H. MA 18.06 Clinical Prognostic Model for Older Patients with Advanced Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 12: S1878-S1879. DOI: 10.1016/J.JTHO.2017.09.625 |
0.301 |
|
2017 |
Herbst R, Redman M, Gandara DR, Hirsch FR, Mack P, Borghaei H, Langer C, Wade J, Engelman J, Edelman M, Albain K, Lara P, Aggarwal C, Socinski M, Gettinger S, ... ... Bradley J, et al. OA 14.07 Progress in Lung Squamous Cell Carcinoma from the Lung-MAP Master Protocol (S1400) Sub-Studies S1400A, S1400B, S1400C and S1400D Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2017.09.412 |
0.347 |
|
2017 |
Wang X, Cao X, Stinchcombe T, Bradley J, Adjei A, Gandara DR, Ramalingam S, Pang H, Vokes E, Crawford J. P2.03a-055 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials: Topic: Clinical Trials Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.1265 |
0.345 |
|
2017 |
Bradley J. SC03.02 Proton Therapy of Lung Cancer Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.071 |
0.39 |
|
2017 |
Jin J, Hu C, Wang W, Zhang H, Yu J, Bentzen S, Deasy J, Xiao Y, Schild S, Bogart J, Dobelbower M, Michalski J, Kavadi V, Narayan S, Iyengar P, ... ... Bradley J, et al. Effect of PTV and Collimator Margins on Tumor Control for Patients with Stage III Non-small Cell Lung Cancer in NRG Oncology RTOG-0617 International Journal of Radiation Oncology*Biology*Physics. 99: S181-S182. DOI: 10.1016/J.Ijrobp.2017.06.455 |
0.498 |
|
2017 |
Jin J, Hu C, Xiao Y, Zhang H, Ellsworth S, Schild S, Bogart J, Dobelbower M, Kavadi V, Narayan S, Iyengar P, Robinson C, Brufsky A, Koprowski C, Machtay M, ... ... Bradley J, et al. Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617) International Journal of Radiation Oncology*Biology*Physics. 99: S151-S152. DOI: 10.1016/J.Ijrobp.2017.06.351 |
0.335 |
|
2017 |
Cai B, Green O, Li H, Rodriguez V, Roach M, Robinson C, Mutic S, Bradley J. Feasibility of Stereotactic Body Radiation Therapy for Non–small Cell Lung Cancer Using a Linear Accelerator-Based Magnetic Resonance Image Guided Radiation Therapy System International Journal of Radiation Oncology*Biology*Physics. 99: E643-E644. DOI: 10.1016/j.ijrobp.2017.06.2154 |
0.304 |
|
2017 |
Samson P, Kozower B, Roach M, DeWees T, Carpenter L, Gal K, Bradley J, Meyers B, Puri V, Robinson C, Crabtree T. Development of a Prospective Clinical Database for Stage I Non–small Cell Lung Cancer Patients to Identify High-Risk Individuals Appropriate for Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E493-E494. DOI: 10.1016/j.ijrobp.2017.06.1782 |
0.348 |
|
2017 |
Samson P, Keogan K, Robinson C, Bradley J, Roach M, Crabtree T, Kozower B, Puri V, Meyers B. Treatment Allocation Modeling for Clinical Stage I Non–small Cell Lung Cancer Patients to Facilitate the Shared Decision Making Process for Stereotactic Body Radiation Therapy Versus Surgical Resection International Journal of Radiation Oncology*Biology*Physics. 99: E493. DOI: 10.1016/J.IJROBP.2017.06.1781 |
0.325 |
|
2017 |
Fischer-Valuck BW, Henke L, Kashani R, Green O, Olsen J, Parikh P, Robinson C, Bradley J, Thomas M, Roach M, Zoberi I, Mazur T, Huang J, Gay H, Rodriguez V, et al. (P097) Two-and-a-Half Year Clinical Experience With Magnetic Resonance Image Guided Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 98: E41-E42. DOI: 10.1016/J.Ijrobp.2017.02.193 |
0.303 |
|
2017 |
Gits CC, Rehman S, Roach MC, Speirs CK, Chundury A, Henke L, Mullen D, DeWees T, Bradley JD, Robinson CG. (P081) Definitive Hypofractionated Radiation in the Treatment of Clinical N1 Non-Small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology*Biology*Physics. 98: E37. DOI: 10.1016/J.IJROBP.2017.02.177 |
0.336 |
|
2017 |
Rehman S, Roach M, Chundury A, Mullen D, DeWees T, Bradley J, Robinson C. S015) Local Control Is Not Dependent on Length of Treatment for 5 Fraction Regimens in Lung Stereotactic Body Radiotherapy (SBRT) International Journal of Radiation Oncology Biology Physics. 98. DOI: 10.1016/J.Ijrobp.2017.02.051 |
0.387 |
|
2016 |
Bradley J, Hu C. Learning From Trials on Radiation Dose in Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: 748-750. PMID 27788947 DOI: 10.1016/J.Ijrobp.2016.08.035 |
0.458 |
|
2016 |
Speirs CK, DeWees TA, Rehman S, Molotievschi A, Velez MA, Mullen D, Fergus S, Trovo M, Bradley JD, Robinson CG. Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27743888 DOI: 10.1016/j.jtho.2016.09.134 |
0.332 |
|
2016 |
Henke L, Kashani R, Yang D, Zhao T, Green O, Olsen L, Rodriguez V, Wooten HO, Li HH, Hu Y, Bradley J, Robinson C, Parikh P, Michalski J, Mutic S, et al. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages. International Journal of Radiation Oncology, Biology, Physics. PMID 27742541 DOI: 10.1016/J.Ijrobp.2016.08.036 |
0.31 |
|
2016 |
Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces Y, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun A, ... ... Bradley JD, et al. Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology, Biology, Physics. 96: S8. PMID 27676020 DOI: 10.1016/J.Ijrobp.2016.06.035 |
0.348 |
|
2016 |
Robinson CG, Samson P, Bradley JD, Roach MC, DeWees TA, Waqar SN, Baggstrom MQ, Govindan R, Higgins KA, Simone CB, Grover S, Puri V, Morgensztern D. Patterns of Care and Survival for Early Versus Delayed Radiation Therapy (RT) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): A Review of the National Cancer Data Base. International Journal of Radiation Oncology, Biology, Physics. 96: E436-E437. PMID 27674686 DOI: 10.1016/j.ijrobp.2016.06.1726 |
0.308 |
|
2016 |
Samson P, Robinson C, Bradley J, Lockhart AC, Puri V, Broderick S, Kreisel D, Krupnick AS, Patterson GA, Meyers B, Crabtree T. Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27544058 DOI: 10.1016/J.Jtho.2016.07.031 |
0.318 |
|
2016 |
Salahudeen AA, Patel MI, Baas P, Curran WJ, Bradley JD, Gandara DR, Goss GD, Mok TS, Ramalingam SS, Vokes EE, Malik SM, Wakelee HA. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe. Clinical Lung Cancer. PMID 27473736 DOI: 10.1016/j.cllc.2016.06.007 |
0.303 |
|
2016 |
Morgensztern D, Du L, Waqar SN, Patel A, Samson P, Devarakonda S, Gao F, Robinson C, Bradley J, Baggstrom M, Masood A, Govindan R, Puri V. Adjuvant Chemotherapy for Patients with T2N0M0 Non-small-cell Lung Cancer (NSCLC). Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27287414 DOI: 10.1016/J.Jtho.2016.05.022 |
0.399 |
|
2016 |
Eaton BR, Pugh SL, Bradley JD, Masters G, Kavadi VS, Narayan S, Nedzi L, Robinson C, Wynn RB, Koprowski C, Johnson DW, Meng J, Curran WJ. Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617. Journal of the National Cancer Institute. 108. PMID 27206636 DOI: 10.1093/jnci/djw034 |
0.346 |
|
2016 |
Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB, Rengan R, Feigenberg S, Khan AJ, Choi NC, Bradley JD, Zhu XR, Lomax AJ, Hoppe BS. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 95: 505-16. PMID 27084663 DOI: 10.1016/j.ijrobp.2016.01.036 |
0.316 |
|
2016 |
Zhao T, Sun B, Grantham K, Rankine L, Cai B, Goddu SM, Santanam L, Knutson N, Zhang T, Reilly M, Bottani B, Bradley J, Mutic S, Klein EE. Commissioning and initial experience with the first clinical gantry-mounted proton therapy system. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 17: 5868. PMID 27074470 DOI: 10.1120/Jacmp.V17I2.5868 |
0.34 |
|
2015 |
Rehman S, Roach MC, Bradley JD, Robinson CG. Lung Stereotactic Body Radiation Therapy. Missouri Medicine. 112: 361-5. PMID 26606817 |
0.344 |
|
2015 |
Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, Kavadi V, Narayan S, Michalski J, Johnson DW, Koprowski C, Curran WJ, Garces YI, Gaur R, Wynn RB, et al. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. Jama Oncology. 1-9. PMID 26606200 DOI: 10.1001/Jamaoncol.2015.3969 |
0.435 |
|
2015 |
Samson P, Robinson CG, Bradley J, Lee A, Broderick S, Kreisel D, Krupnick AS, Patterson GA, Puri V, Meyers BF, Crabtree T. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. PMID 26410001 DOI: 10.1016/J.Jtcvs.2015.08.058 |
0.408 |
|
2015 |
Waqar SN, Waqar SH, Trinkaus K, Gadea CA, Robinson CG, Bradley J, Watson MA, Puri V, Govindan R, Morgensztern D. Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. PMID 26359696 DOI: 10.1097/Coc.0000000000000230 |
0.353 |
|
2015 |
Roach MC, Videtic GM, Bradley JD. Treatment of Peripheral Non-Small Cell Lung Carcinoma with Stereotactic Body Radiation Therapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 1261-7. PMID 26291009 DOI: 10.1097/JTO.0000000000000610 |
0.344 |
|
2015 |
Fontanella A, Jeong J, Sonke J, Bradley J, Chen C, Deasy J. TH-AB-304-03: Tumor Control Probability Applied to Lung Cancer: A Statistical Test of the Independence of Voxel Response. Medical Physics. 42: 3701. PMID 26129421 DOI: 10.1118/1.4926118 |
0.453 |
|
2015 |
Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GM. Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Practical Radiation Oncology. 5: 149-55. PMID 25957185 DOI: 10.1016/J.Prro.2015.02.013 |
0.413 |
|
2015 |
Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GM. Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Practical Radiation Oncology. 5: 141-8. PMID 25957184 DOI: 10.1016/j.prro.2015.02.012 |
0.351 |
|
2015 |
Rodrigues G, Oberije C, Senan S, Tsujino K, Wiersma T, Moreno-Jimenez M, Kim TH, Marks LB, Rengan R, De Petris L, Ramella S, DeRuyck K, De Dios NR, Warner A, Bradley JD, et al. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis. International Journal of Radiation Oncology, Biology, Physics. 91: 133-9. PMID 25835622 DOI: 10.1016/j.ijrobp.2014.09.033 |
0.382 |
|
2015 |
Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. The Lancet. Oncology. 16: 187-99. PMID 25601342 DOI: 10.1016/S1470-2045(14)71207-0 |
0.337 |
|
2015 |
Lilenbaum R, Samuels M, Wang X, Kong FM, Jänne PA, Masters G, Katragadda S, Hodgson L, Bogart J, Bradley J, Vokes E. A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG). Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 143-7. PMID 25384173 DOI: 10.1097/Jto.0000000000000347 |
0.436 |
|
2015 |
Robinson CG, Patel A, Bradley JD, DeWees TA, Rehman S, Roach MC, Morgensztern D, Crabtree T, Puri V. Survival following stereotactic body radiation therapy or conventionally fractionated radiation for definitive non-operative treatment of stage I non-small cell lung cancer: A review of the National Cancer Data Base. Journal of Clinical Oncology. 33: 7513-7513. DOI: 10.1200/JCO.2015.33.15_SUPPL.7513 |
0.351 |
|
2015 |
Bradley J, Gao F, Parikh P, Roach M, Rehman S, Kashani R, Ganachaud J, Stroud J, DeWees T, Robinson C. Prospective Phase 2 Clinical Trial of Radiation Dose-Escalated Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Lung Cancer: An Institutional Trial International Journal of Radiation Oncology*Biology*Physics. 93: S101. DOI: 10.1016/J.Ijrobp.2015.07.242 |
0.335 |
|
2015 |
Rehman S, Roach M, Mullen D, DeWees T, Bradley J, Robinson C. Stereotactic Body Radiation Therapy (SBRT) for Treatment of Lung Oligometastases International Journal of Radiation Oncology*Biology*Physics. 93: E404-E405. DOI: 10.1016/J.IJROBP.2015.07.1579 |
0.315 |
|
2014 |
Fontanella A, Robinson C, Zuniga A, Apte A, Thorstad W, Bradley J, Deasy J. SU-E-T-312: Test of the Generalized Tumor Dose (gTD) Model with An Independent Lung Tumor Dataset. Medical Physics. 41: 296. PMID 28037913 DOI: 10.1118/1.4888644 |
0.47 |
|
2014 |
Stanic S, Paulus R, Timmerman RD, Michalski JM, Barriger RB, Bezjak A, Videtic GM, Bradley J. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. International Journal of Radiation Oncology, Biology, Physics. 88: 1092-9. PMID 24661663 DOI: 10.1016/J.Ijrobp.2013.12.050 |
0.463 |
|
2014 |
Li H, Bottani B, DeWees T, Low DA, Michalski JM, Mutic S, Bradley JD, Robinson CG. Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer. Medical Physics. 41: 031708. PMID 24593712 DOI: 10.1118/1.4865766 |
0.326 |
|
2014 |
Crabtree TD, Puri V, Robinson C, Bradley J, Broderick S, Patterson GA, Liu J, Musick JF, Bell JM, Yang M, Meyers BF. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. The Journal of Thoracic and Cardiovascular Surgery. 147: 1183-1191; discussio. PMID 24507980 DOI: 10.1016/J.Jtcvs.2013.11.057 |
0.409 |
|
2014 |
Waqar SN, Robinson C, Bradley J, Goodgame B, Rooney M, Williams K, Gao F, Govindan R. A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer. Clinical Lung Cancer. 15: 119-23. PMID 24373609 DOI: 10.1016/J.Cllc.2013.11.007 |
0.483 |
|
2014 |
Eaton BR, Pugh SL, Bradley JD, Kavadi V, Narayan S, Nedzi LA, Robinson CG, Deutsch M, Koprowski CD, Johnson DW, Meng J, Curran WJ. The effect of institutional clinical trial enrollment volume on survival of patients with stage III non-small cell lung cancer treated with chemoradiation: A report of the Radiation Therapy Oncology Group (RTOG) 0617. Journal of Clinical Oncology. 32: 7551-7551. DOI: 10.1200/JCO.2014.32.15_SUPPL.7551 |
0.347 |
|
2014 |
Ohri N, Duan F, Machtay M, Gorelick JJ, Snyder BS, Alavi A, Siegel B, Johnson DW, Bradley JD, DeNittis AS, Werner-Wasik M. Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 : Locally Advanced Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.166 |
0.341 |
|
2014 |
Rehman S, Speirs C, Molotievschi A, Mullen D, Fergus S, DeWees T, Velez M, Bradley J, Robinson C. Evaluating a Nomogram for the Development of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated With 3D and Intensity Modulated Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 90: S161-S162. DOI: 10.1016/J.IJROBP.2014.05.654 |
0.344 |
|
2014 |
Roach M, Rehman S, DeWees T, Mullen D, Bradley J, Robinson C. Stereotactic Body Radiation Therapy for the Treatment of Multiple Primary Non-Small Cell Lung Carcinoma International Journal of Radiation Oncology*Biology*Physics. 90: S158. DOI: 10.1016/J.IJROBP.2014.05.646 |
0.313 |
|
2014 |
Ohri N, Duan F, Machtay M, Gorelick JJ, Snyder BS, Alavi A, Siegel B, Johnson DW, Bradley JD, DeNittis AS, Werner-Wasik M. Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.612 |
0.317 |
|
2014 |
Speirs C, Rehman S, Molotievschi A, Velez M, DeWees T, Mullen D, Fergus S, Bradley J, Robinson C. Comprehensive Analysis of Dosimetric Predictors of Overall Survival for Stage III Non-Small Cell Lung Cancer (NSCLC) Treated With Definitive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 90: S667. DOI: 10.1016/J.IJROBP.2014.05.1964 |
0.342 |
|
2014 |
Timmerman R, Hu C, Michalski J, Straube W, Galvin J, Johnstone D, Bradley J, Barriger R, Bezjak A, Videtic G, Nedzi L, Werner-Wasik M, Chen Y, Komaki R, Choy H. Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S30. DOI: 10.1016/J.IJROBP.2014.05.135 |
0.311 |
|
2014 |
Giaddui T, Gong Y, Yu J, Chen W, Gore E, Wheatley M, Feng-Meng (Spring) K, Bradley J, Xiao Y, Bar Ad V. Interobserver Variability in Esophageal Contours for Patients With Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Therapy: RTOG 0617 Experience International Journal of Radiation Oncology*Biology*Physics. 90: S347. DOI: 10.1016/J.IJROBP.2014.05.1133 |
0.306 |
|
2013 |
Oh J, Bradley J, Deasy J. SU-D-137-01: Prediction of Multi-Categorical Radiation Pneumonitis Status in Lung Cancer Patients Using Machine Learning Approaches. Medical Physics. 40: 101-102. PMID 28519578 DOI: 10.1118/1.4814004 |
0.474 |
|
2013 |
Lee S, Bradley J, Ybarra N, Jeyaseelan K, Seuntjens J, El Naqa I. TU-G-108-05: Assessment of Different Machine Learning Techniques for Multivariate Radiation Pneumonitis Modeling. Medical Physics. 40: 454. PMID 28518793 DOI: 10.1118/1.4815454 |
0.382 |
|
2013 |
Huang E, Folkert M, Bradley J, Apte A, Deasy J. TU-G-108-02: Left Atrium Dose-Volume Parameters Predict for Clinically Significant Radiation Pneumonitis. Medical Physics. 40: 453. PMID 28518774 DOI: 10.1118/1.4815451 |
0.557 |
|
2013 |
Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD, Barriger RB, Moreno-Jiménez M, Kim TH, Ramella S, Everitt S, Rengan R, Marks LB, De Ruyck K, Warner A, et al. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. International Journal of Radiation Oncology, Biology, Physics. 87: 690-6. PMID 24035329 DOI: 10.1016/j.ijrobp.2013.07.029 |
0.369 |
|
2013 |
White B, Zhao T, Lamb J, Wuenschel S, Bradley J, El Naqa I, Low D. Distribution of lung tissue hysteresis during free breathing. Medical Physics. 40: 043501. PMID 23556925 DOI: 10.1118/1.4794504 |
0.357 |
|
2013 |
Lin SH, George TJ, Ben-Josef E, Bradley J, Choe KS, Edelman MJ, Guha C, Krishnan S, Lawrence TS, Le QT, Lu B, Mehta M, Peereboom D, Sarkaria J, Seong J, et al. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy. Journal of the National Cancer Institute. 105: 686-93. PMID 23503600 DOI: 10.1093/Jnci/Djt055 |
0.396 |
|
2013 |
Robinson CG, DeWees TA, El Naqa IM, Creach KM, Olsen JR, Crabtree TD, Meyers BF, Puri V, Bell JM, Parikh PJ, Bradley JD. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 192-201. PMID 23287852 DOI: 10.1097/Jto.0B013E31827Ce361 |
0.302 |
|
2013 |
Badiyan SN, Bierhals AJ, Olsen JR, Creach KM, Garsa AA, Dewees T, Bradley JD, Robinson CG. Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. Radiation Oncology (London, England). 8: 4. PMID 23286648 DOI: 10.1186/1748-717X-8-4 |
0.317 |
|
2013 |
Crabtree T, Puri V, Timmerman R, Fernando H, Bradley J, Decker PA, Paulus R, Putnum JB, Dupuy DE, Meyers B. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). The Journal of Thoracic and Cardiovascular Surgery. 145: 692-9. PMID 23174176 DOI: 10.1016/J.Jtcvs.2012.10.038 |
0.353 |
|
2013 |
Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, Bradley JD, Kim TH, Ramella S, Marks LB, De Petris L, Stitt L, Rodrigues G. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. International Journal of Radiation Oncology, Biology, Physics. 85: 444-50. PMID 22682812 DOI: 10.1016/j.ijrobp.2012.04.043 |
0.396 |
|
2013 |
Santanam L, Brame RS, Lindsey A, Dewees T, Danieley J, Labrash J, Parikh P, Bradley J, Zoberi I, Michalski J, Mutic S. Eliminating inconsistencies in simulation and treatment planning orders in radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 85: 484-91. PMID 22572077 DOI: 10.1016/J.Ijrobp.2012.03.023 |
0.303 |
|
2013 |
Zuniga A, Apte A, Bradley J, Thorstad W, Deasy J. SU-E-T-244: Interfractional Motion Simulation of Head and Neck and Lung Patients Correlated to Treatment Outcome Medical Physics. 40: 260-260. DOI: 10.1118/1.4814679 |
0.468 |
|
2013 |
Robinson CG, DeWees T, Naqa IME, Creach KM, Olsen JR, Crabtree TD, Meyers BF, Puri V, Bell JM, Parikh PJ, Bradley JD. Erratum: Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage i non-small-cell lung cancer (Journal of Thoracic Oncology (2013) 8 (192-201)) Journal of Thoracic Oncology. 8. DOI: 10.1097/Jto.0000000000000004 |
0.334 |
|
2013 |
Deasy J, Zuniga A, Apte A, Thorstad W, Bradley J. A New Tumor Control Probability Model Fitted to Head-and-Neck and Lung Local Control Data and Resulting Implications for the Impact of Dose Heterogeneity International Journal of Radiation Oncology*Biology*Physics. 87: S694. DOI: 10.1016/J.Ijrobp.2013.06.1841 |
0.478 |
|
2013 |
Papachristofilou A, Nader D, Roeder F, Bradley J, Parikh P, Schratzenstaller I, Payne M, Gompelmann D, Paris G, Pu A. Clinical Utilization of Electromagnetic Real-Time Lung Tumor Localization During Radiation Therapy: A Prospective International Multicenter Study International Journal of Radiation Oncology*Biology*Physics. 87: S35. DOI: 10.1016/J.Ijrobp.2013.06.093 |
0.313 |
|
2012 |
Komaki R, Paulus R, Ettinger DS, Videtic GM, Bradley JD, Glisson BS, Langer CJ, Sause WT, Curran WJ, Choy H. Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. International Journal of Radiation Oncology, Biology, Physics. 83: e531-6. PMID 22560543 DOI: 10.1016/j.ijrobp.2012.01.075 |
0.385 |
|
2012 |
Machtay M, Paulus R, Moughan J, Komaki R, Bradley JE, Choy H, Albain K, Movsas B, Sause WT, Curran WJ. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 716-22. PMID 22425920 DOI: 10.1097/Jto.0B013E3182429682 |
0.462 |
|
2012 |
Puri V, Crabtree TD, Kymes S, Gregory M, Bell J, Bradley JD, Robinson C, Patterson GA, Kreisel D, Krupnick AS, Meyers BF. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. The Journal of Thoracic and Cardiovascular Surgery. 143: 428-36. PMID 22169443 DOI: 10.1016/j.jtcvs.2011.10.078 |
0.346 |
|
2012 |
Vaidya M, Creach KM, Frye J, Dehdashti F, Bradley JD, El Naqa I. Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 102: 239-45. PMID 22098794 DOI: 10.1016/j.radonc.2011.10.014 |
0.329 |
|
2012 |
Huang EX, Bradley JD, El Naqa I, Hope AJ, Lindsay PE, Bosch WR, Matthews JW, Sause WT, Graham MV, Deasy JO. Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients. International Journal of Radiation Oncology, Biology, Physics. 82: 1674-9. PMID 21658856 DOI: 10.1016/J.Ijrobp.2011.02.052 |
0.553 |
|
2012 |
Bradley J, Bae K, Choi N, Forster K, Siegel BA, Brunetti J, Purdy J, Faria S, Vu T, Thorstad W, Choy H. A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. International Journal of Radiation Oncology, Biology, Physics. 82: 435-41.e1. PMID 21075551 DOI: 10.1016/J.Ijrobp.2010.09.033 |
0.388 |
|
2012 |
Zuniga A, Thorstad W, Bradley J, Deasy J. TH‐C‐213AB‐08: The Cell‐Kill‐Based Equivalent Uniform Dose (cEUD) Predictor: A Modification to Account for Increasing Radioresistance with Increasing Tumor Volume Medical Physics. 39: 3995-3995. DOI: 10.1118/1.4736297 |
0.438 |
|
2012 |
Lee S, Bradley J, Ybarra N, Jeyaseelan K, Seuntjens J, Naqa ie. TH‐C‐213AB‐03: Bayesian Network Framework for Biophysical Radiation Pneumonitis Modeling Medical Physics. 39: 3993-3994. DOI: 10.1118/1.4736292 |
0.34 |
|
2012 |
Oh J, Apte A, Robinson C, Bradley J, Deasy J. TH-C-213AB-02: Improved Predictive Modeling of Radiation Pneumonitis in Lung Cancer Patients Using Machine Learning Techniques Medical Physics. 39: 3993-3993. DOI: 10.1118/1.4736291 |
0.472 |
|
2012 |
Papachristofilou A, Nader D, Roeder F, Bradley J, Bolliger C, Schratzenstaller U, Payne M, Gompelmann D, Robinson C, Paris G. Prospective International Trial of Endobronchial Implantation of Electromagnetic Fiducials for Localization and Real-time Tracking of Tumors in Lung Cancer Patients Undergoing Radiation Therapy (RT) International Journal of Radiation Oncology*Biology*Physics. 84: S175. DOI: 10.1016/J.IJROBP.2012.07.453 |
0.325 |
|
2012 |
DeWees T, Creach K, Olsen J, Bradley J, Robinson C. Defining Optimal Comorbidity Measures for Patients With Medically Inoperable Early-stage Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Body Radiation Therapy (SBRT) International Journal of Radiation Oncology*Biology*Physics. 84: S172. DOI: 10.1016/J.IJROBP.2012.07.446 |
0.326 |
|
2012 |
Molotievschi A, DeWees T, Eschen L, Mullen D, Clohisy J, Brandon J, Bradley J, Robinson C. Late Esophageal Stricture Correlates With Decreased Overall Survival for Locally Advanced Non-small Cell Lung Cancer Treated With Radiation Therapy: A Potential Confounder of Dose Escalation? International Journal of Radiation Oncology*Biology*Physics. 84: S154-S155. DOI: 10.1016/J.IJROBP.2012.07.398 |
0.374 |
|
2012 |
Stanic S, Paulus R, Timmerman R, Michalski J, Barriger R, Bezjak A, Videtic G, Bradley J. No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236 International Journal of Radiation Oncology*Biology*Physics. 84: S48. DOI: 10.1016/J.IJROBP.2012.07.334 |
0.329 |
|
2012 |
Palma D, Senan S, Tsujino K, Barriger R, Rengan R, Moreno M, Bradley J, Hyun Kim T, Marks L, Rodrigues G. Predicting Symptomatic Radiation Pneumonitis After Concurrent Chemoradiation Therapy for Non-small Cell Lung Cancer: Results of an International Individual Patient Data Meta-analysis International Journal of Radiation Oncology*Biology*Physics. 84: S549. DOI: 10.1016/J.IJROBP.2012.07.1464 |
0.369 |
|
2012 |
Deasy J, Robinson C, Huang E, Molotievschi A, Bradley J. Independent Test of a Model to Predict Radiation Pneumonitis After Definitive Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer: Heart Irradiation is (Again) a Statistically Significant Risk Factor International Journal of Radiation Oncology*Biology*Physics. 84: S32. DOI: 10.1016/J.Ijrobp.2012.07.087 |
0.504 |
|
2012 |
Matuszak MM, Xiao Y, Presley J, Bosch WR, Haken RKT, Galvin J, Werner-Wasik M, Machtay M, Bradley J, Kong F. The Importance of Dry Run Credentialing for RTOG 1106/ACRIN 6697: A Trial of Individualized Adaptive Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.074 |
0.458 |
|
2011 |
Rodrigues G, Videtic GM, Sur R, Bezjak A, Bradley J, Hahn CA, Langer C, Miller KL, Moeller BJ, Rosenzweig K, Movsas B. Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline. Practical Radiation Oncology. 1: 60-71. PMID 25740118 DOI: 10.1016/j.prro.2011.01.005 |
0.334 |
|
2011 |
Oh JH, Craft J, Al Lozi R, Vaidya M, Meng Y, Deasy JO, Bradley JD, El Naqa I. A Bayesian network approach for modeling local failure in lung cancer. Physics in Medicine and Biology. 56: 1635-51. PMID 21335651 DOI: 10.1088/0031-9155/56/6/008 |
0.519 |
|
2011 |
Oh JH, Craft JM, Townsend R, Deasy JO, Bradley JD, El Naqa I. A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data. Journal of Proteome Research. 10: 1406-15. PMID 21226504 DOI: 10.1021/Pr101226Q |
0.489 |
|
2011 |
Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, Bradley JD. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncologica (Stockholm, Sweden). 50: 51-60. PMID 20874426 DOI: 10.3109/0284186X.2010.521192 |
0.524 |
|
2011 |
Linda A, Trovo M, Bradley JD. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. European Journal of Radiology. 79: 147-54. PMID 19954913 DOI: 10.1016/j.ejrad.2009.10.029 |
0.397 |
|
2011 |
Chawla A, Marks L, Deasy J, Bradley J, Das S. WE-G-BRA-01: A Framework to Determine Risk of Pneumonitis Following Radiotherapy for Lung Cancer Medical Physics. 38: 3826-3826. DOI: 10.1118/1.3613406 |
0.496 |
|
2011 |
Zuniga AA, Thorstad W, oh JH, Apte AP, Bradley J, Deasy JO. SU-E-T-38: Validating the Use of a New Tumor Irradiation Quality Metric for Lung and Head and Neck Tumors: Total Clonogen Survival Medical Physics. 38: 3494-3494. DOI: 10.1118/1.3611989 |
0.488 |
|
2011 |
Oh J, Zuniga A, Thorstad W, Bradley J, Deasy J. SU-E-T-01: Tumor Control Probability Models Derived Using Machine Learning for Head and Neck and Lung Tumors including a New Metric, Total Clonogen Survival (TCS) Medical Physics. 38: 3485-3485. DOI: 10.1118/1.3611951 |
0.506 |
|
2011 |
Oh J, Craft J, Al-Lozi R, Vaidya M, Meng Y, Bradley J, Deasy J, El Naqa I. 1512 poster INTEGRATING DOSIMETRY AND BIOMARKERS VIA A BAYESIAN NETWORK FOR PREDICTING RADIOTHERAPY RESPONSE IN LUNG CANCER Radiotherapy and Oncology. 99: S563. DOI: 10.1016/S0167-8140(11)71634-6 |
0.477 |
|
2011 |
Zuniga A, Hope A, Lindsay P, Bradley J, Deasy J. 452 poster TESTING WHETHER THE CELL-KILL-BASED EQUIVALENT UNIFORM DOSE (CEUD) FORMULA PREDICTS LOCAL CONTROL FOR NON-SMALL-CELL LUNG CANCER Radiotherapy and Oncology. 99: S182. DOI: 10.1016/S0167-8140(11)70574-6 |
0.507 |
|
2011 |
Mahowald G, DeWeese T, Olsen J, Creach K, Mullen D, Fergus S, Bradley J, Robinson C. Clinical and Dosimetric Factors Predicting for Radiation Pneumonitis following Lung SBRT International Journal of Radiation Oncology*Biology*Physics. 81: S167. DOI: 10.1016/J.IJROBP.2011.06.1671 |
0.344 |
|
2011 |
Chawla A, Marks L, Deasy J, Bradley J, Das S. Testing a Framework to Predict the Risk of Lung Pneumonitis after Thoracic Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 81: S803. DOI: 10.1016/J.Ijrobp.2011.06.1408 |
0.543 |
|
2011 |
El Naqa I, Bradley J, Oh J, Craft J, Deasy J. Investigating Alpha-2-Macroglobulin and Its Dosimetric Interactions for Predicting Radiation Pneumonitis International Journal of Radiation Oncology*Biology*Physics. 81: S756-S757. DOI: 10.1016/J.Ijrobp.2011.06.1259 |
0.404 |
|
2010 |
Bradley J. New territory: surgical salvage for stereotactic body radiation therapy failures in lung cancer. Journal of Thoracic Oncology. 5: 1879-1880. PMID 21102255 DOI: 10.1097/Jto.0B013E318200Dea6 |
0.458 |
|
2010 |
Dehing-Oberije C, De Ruysscher D, Petit S, Van Meerbeeck J, Vandecasteele K, De Neve W, Dingemans AM, El Naqa I, Deasy J, Bradley J, Huang E, Lambin P. Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 97: 455-61. PMID 21084125 DOI: 10.1016/J.Radonc.2010.09.028 |
0.591 |
|
2010 |
Chang AJ, Bradley JD. Clinical perspectives on dose escalation for non-small-cell lung cancer. Clinical Lung Cancer. 11: 299-302. PMID 20837454 DOI: 10.3816/CLC.2010.n.037 |
0.376 |
|
2010 |
Robinson CG, Bradley JD. The treatment of early-stage disease Seminars in Radiation Oncology. 20: 178-185. PMID 20685580 DOI: 10.1016/j.semradonc.2010.01.004 |
0.304 |
|
2010 |
Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. International Journal of Radiation Oncology, Biology, Physics. 77: 367-72. PMID 20457350 DOI: 10.1016/j.ijrobp.2009.04.029 |
0.342 |
|
2010 |
Crabtree TD, Denlinger CE, Meyers BF, El Naqa I, Zoole J, Krupnick AS, Kreisel D, Patterson GA, Bradley JD. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. 140: 377-86. PMID 20400121 DOI: 10.1016/j.jtcvs.2009.12.054 |
0.351 |
|
2010 |
Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2475-80. PMID 20368547 DOI: 10.1200/JCO.2009.27.1205 |
0.365 |
|
2010 |
Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama. 303: 1070-6. PMID 20233825 DOI: 10.1001/Jama.2010.261 |
0.416 |
|
2010 |
Naqa IE, Deasy JO, Mu Y, Huang E, Hope AJ, Lindsay PE, Apte A, Alaly J, Bradley JD. Datamining approaches for modeling tumor control probability. Acta Oncologica (Stockholm, Sweden). 49: 1363-73. PMID 20192878 DOI: 10.3109/02841861003649224 |
0.442 |
|
2010 |
Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, El Naqa I, Hubbs JL, Lebesque JV, Timmerman RD, Martel MK, Jackson A. Radiation dose-volume effects in the lung. International Journal of Radiation Oncology, Biology, Physics. 76: S70-6. PMID 20171521 DOI: 10.1016/J.Ijrobp.2009.06.091 |
0.511 |
|
2010 |
Trovo M, Linda A, Naqa IE, Javidan-Nejad C, Bradley J. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer. 69: 77-85. PMID 19910075 DOI: 10.1016/J.Lungcan.2009.09.006 |
0.381 |
|
2010 |
Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. International Journal of Radiation Oncology, Biology, Physics. 77: 1146-50. PMID 19800181 DOI: 10.1016/j.ijrobp.2009.06.017 |
0.356 |
|
2010 |
Huang E, Bradley J, El Naqa I, Pesce L, Deasy J. SU-GG-T-444: Normal Tissue Complication Probability (NTCP) Modeling Using Self-Organizing Map (SOM) Medical Physics. 37: 3288-3288. DOI: 10.1118/1.3468842 |
0.468 |
|
2010 |
Zhao T, White B, Mutic S, Lu W, Bradley J, Parikh P, Low D. SU-GG-J-86: Impact of Hysteresis on Breathing Motion and Its Distribution Medical Physics. 37: 3165-3165. DOI: 10.1118/1.3468310 |
0.313 |
|
2010 |
Oh JH, Craft J, Al-Lozi R, Vaidya M, Meng Y, Deasy JO, Bradley JD, El Naqa I. Predicting local failure in lung cancer using Bayesian networks Proceedings - 9th International Conference On Machine Learning and Applications, Icmla 2010. 735-739. DOI: 10.1109/ICMLA.2010.112 |
0.465 |
|
2010 |
Heinzerling JH, Choy H, Hughes RS, Govindan R, Bradley JD, Schwartzberg LS, Peng G, Treat J, Tran T, Obasaju C. Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer: A Phase I Trial Journal of Thoracic Oncology. 5: 1391-1396. DOI: 10.1097/JTO.0b013e3181e7fe43 |
0.35 |
|
2010 |
Oh J, Craft J, Al-Lozi R, Vaidya M, Meng Y, Deasy J, Bradley J, El Naqa I. A Bayesian Network Approach for Predicting Local Failure in Lung Cancer using Physical and Biological Variables International Journal of Radiation Oncology*Biology*Physics. 78: S659-S660. DOI: 10.1016/J.Ijrobp.2010.07.1536 |
0.455 |
|
2010 |
Craft J, Oh J, Ju M, Bradley J, Deasy J, El Naqa I. Quantitative Mass Spectroscopy and the Identification of Alpha2macroglobulin as a Potential Biomarker for Radiation Pneumonitis International Journal of Radiation Oncology*Biology*Physics. 78: S498-S499. DOI: 10.1016/J.Ijrobp.2010.07.1166 |
0.408 |
|
2009 |
Spencer SJ, Bonnin DA, Deasy JO, Bradley JD, El Naqa I. Bioinformatics methods for learning radiation-induced lung inflammation from heterogeneous retrospective and prospective data. Journal of Biomedicine & Biotechnology. 2009: 892863. PMID 19704920 DOI: 10.1155/2009/892863 |
0.544 |
|
2009 |
El Naqa I, Bradley JD, Lindsay PE, Hope AJ, Deasy JO. Predicting radiotherapy outcomes using statistical learning techniques. Physics in Medicine and Biology. 54: S9-S30. PMID 19687564 DOI: 10.1088/0031-9155/54/18/S02 |
0.412 |
|
2009 |
Bradley J. So Far, So Good for Lung Cancer SBRT Journal of Thoracic Oncology. 4: 781-782. PMID 19550239 DOI: 10.1097/Jto.0B013E3181A99Bda |
0.481 |
|
2009 |
El Naqa I, Bradley J, Deasy J. WE-D-303A-08: Nonlinear Kernels as a Visual Analytics Tool for Radiotherapy Treatment Outcomes Medical Physics. 36: 2777-2777. DOI: 10.1118/1.3182535 |
0.435 |
|
2009 |
Huang E, Bradley J, Naqa Ie, Trovo M, Deasy J. TU-C-BRB-08: Validating Normal Tissue Complication Probability Models: A Study of Generalizability and Datapooling for Predictive Radiation Pneumonitis Modeling Medical Physics. 36: 2723-2723. DOI: 10.1118/1.3182333 |
0.535 |
|
2009 |
Huang E, Lindsay P, Hope A, El Naqa I, Bradley J, Deasy J. SU-FF-T-501: The Effect of Monte Carlo-Based Dose Calculations On Tumor Control Probability Modeling Medical Physics. 36: 2638-2638. DOI: 10.1118/1.3181999 |
0.458 |
|
2009 |
El Naqa I, Vaidya M, Apte A, Fergus S, Deasy J, Bradley J. SU-FF-J-20: A Multimodality Imaging Approach for Predicting Radiation Induced Lung Injury Medical Physics. 36: 2479-2479. DOI: 10.1118/1.3181312 |
0.453 |
|
2009 |
Deasy J, Bradley J, El Naqa I, Huang E, Bosch W, Matthews J, Graham M. PREDICTING THE RISK OF ACUTE ESOPHAGITIS BASED ON DOSE-VOLUME FACTORS: COMBINED MODELING OF RTOG 93-11 AND INSTITUTIONAL DATA Radiotherapy and Oncology. 92: S38. DOI: 10.1016/S0167-8140(12)72684-1 |
0.447 |
|
2009 |
Craft J, Spencer S, Al-Lozi R, Bradley J, Deasy J, El Naqa I. Integrating Serum Biomarkers and Dose–volume Metrics to Predict Radiation Pneumonitis International Journal of Radiation Oncology*Biology*Physics. 75: S108-S109. DOI: 10.1016/J.Ijrobp.2009.07.263 |
0.427 |
|
2009 |
Santanam L, Bradley J, Noel C, Esthappan J, ElNaqa I, Parikh P. Increased Risk of Marginal Miss when using Cone Beam Computed Tomography Imaging Alone for Delivery of Stereotactic Body Radiation Therapy to Abdominal Targets International Journal of Radiation Oncology*Biology*Physics. 75: S671-S672. DOI: 10.1016/J.Ijrobp.2009.07.1533 |
0.328 |
|
2009 |
Komaki R, Paulus R, Ettinger D, Videtic G, Bradley J, Glisson B, Choy H. Patterns of First Failure in a Phase II Study of Accelerated High Dose Thoracic Radiation Therapy (TRT) with Concurrent Chemotherapy for Limited Small-cell Lung Cancer (LSCLC): Radiation Therapy Oncology Group (RTOG) 0239 International Journal of Radiation Oncology*Biology*Physics. 75: S34-S35. DOI: 10.1016/J.IJROBP.2009.07.101 |
0.336 |
|
2009 |
Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Choy H. Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG 0236 International Journal of Radiation Oncology*Biology*Physics. 75: S3. DOI: 10.1016/J.IJROBP.2009.07.033 |
0.315 |
|
2009 |
El Naqa I, Vaidya M, Apte A, Dehdashti F, Deasy JO, Bradley JD. Predicting response in lung cancer from FDG-PET uptake characteristics Ifmbe Proceedings. 25: 656-659. DOI: 10.1007/978-3-642-03474-9-184 |
0.459 |
|
2008 |
Trovo M, Bradley J, El Naqa I, Foster E, Meyers B, Govindan R, Patterson A. Esophageal carcinoma with celiac nodal metastases; curative or palliative? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 751-5. PMID 18594321 DOI: 10.1097/Jto.0B013E31817C7411 |
0.382 |
|
2008 |
Goodgame B, Viswanathan A, Miller CR, Gao F, Meyers B, Battafarano RJ, Patterson A, Cooper J, Guthrie TJ, Bradley J, Pillot G, Govindan R. A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer. American Journal of Clinical Oncology. 31: 22-8. PMID 18376223 DOI: 10.1097/Coc.0B013E3180Ca77D1 |
0.381 |
|
2008 |
Santanam L, Malinowski K, Hubenshmidt J, Dimmer S, Mayse ML, Bradley J, Chaudhari A, Lechleiter K, Goddu SK, Esthappan J, Mutic S, Low DA, Parikh P. Fiducial-based translational localization accuracy of electromagnetic tracking system and on-board kilovoltage imaging system. International Journal of Radiation Oncology, Biology, Physics. 70: 892-9. PMID 18262100 DOI: 10.1016/J.Ijrobp.2007.10.005 |
0.301 |
|
2008 |
Werner-Wasik M, Swann RS, Bradley J, Graham M, Emami B, Purdy J, Sause W. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 70: 385-90. PMID 17869017 DOI: 10.1016/J.Ijrobp.2007.06.034 |
0.428 |
|
2008 |
Bradley J, Movsas B. Radiation Pneumonitis and Esophagitis in Thoracic Irradiation Cancer Treatment and Research. 128: 43-64. PMID 16335013 DOI: 10.1007/0-387-25354-8_4 |
0.357 |
|
2008 |
Huang E, Hope A, Lindsay P, Bradley J, Deasy J. SU-GG-T-404: The Impact of Breathing-Motion and Tumor Regression On Dose-Volume Metrics Used for Outcome Analyses Medical Physics. 35: 2817-2817. DOI: 10.1118/1.2962153 |
0.46 |
|
2008 |
ElNaqa I, Nofal A, Trovo M, Apte A, Yang D, Bradley J, Deasy J, Low D. SU-DD-A4-02: Assessment of PET Estimated Tumor Volume by Four-Dimensional Computed Tomography Measurements Medical Physics. 35: 2635-2635. DOI: 10.1118/1.2961369 |
0.427 |
|
2008 |
El Naqa I, Bradley JD, Deasy JO. Nonlinear kernel-based approaches for predicting normal tissue toxicities Proceedings - 7th International Conference On Machine Learning and Applications, Icmla 2008. 539-544. DOI: 10.1109/ICMLA.2008.126 |
0.442 |
|
2008 |
Yalavarthy PK, Low D, Noel C, Wei Z, Yang D, Apte A, Bradley J, Deasy J, El Naqa I. Current role of PET in oncology: Potentials and challenges in the management of non-small cell lung cancer Conference Record - Asilomar Conference On Signals, Systems and Computers. 1067-1071. DOI: 10.1109/ACSSC.2008.5074576 |
0.463 |
|
2008 |
Deasy JO, Trovo M, Huang EX, Mu Y, Naqa IE, Bradley JD. Poster Discussion PresentationHigh-dose Heart Irradiation is a Statistically Significant Risk Factor for Radiation Pneumonitis within Logistic-multivariate Modeling International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.411 |
0.469 |
|
2008 |
Naqa E, Bradley J, Guild C, Apte A, Fergus S, Dehdashti F, Siegel B, Deasy J. Pattern Recognition Analysis of FDG-PET Uptake Characteristics for Assessing Response in NSCLC Post-radiotherapy Treatment International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.398 |
0.391 |
|
2008 |
Santanam L, Esthappan J, Noel C, Mutic S, Hubenschmidt J, Garcia J, Drzymala R, Low D, Bradley J, Parikh P. A Novel Tool for Image Guided Gated Radiation Therapy Delivery International Journal of Radiation Oncology*Biology*Physics. 72: S623-S624. DOI: 10.1016/J.Ijrobp.2008.06.269 |
0.33 |
|
2008 |
Huang E, Bradley J, Trovo M, Mu Y, El Naqa I, Apte A, Khullar D, Deasy J. High-dose Bronchial Irradiation is a Statistically Significant Risk Factor for Radiation Pneumonitis within Logistic-multivariate Modeling International Journal of Radiation Oncology*Biology*Physics. 72: S452-S453. DOI: 10.1016/J.Ijrobp.2008.06.1840 |
0.478 |
|
2008 |
Mu Y, Hope A, Lindsay P, El Naqa I, Apte A, Deasy J, Bradley J. Statistical Modeling of Tumor Control Probability for Non-small-cell Lung Cancer Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 72: S448. DOI: 10.1016/J.Ijrobp.2008.06.1829 |
0.505 |
|
2007 |
El Naqa I, Yang D, Apte A, Khullar D, Mutic S, Zheng J, Bradley JD, Grigsby P, Deasy JO. Concurrent multimodality image segmentation by active contours for radiotherapy treatment planning. Medical Physics. 34: 4738-49. PMID 18196801 DOI: 10.1118/1.2799886 |
0.44 |
|
2007 |
Velcheti V, Gilstrap E, Bradley J, Govindan R. Radiation-Induced Myonecrosis Presenting as a Subcutaneous Mass After Combined Modality Therapy for Non-small Cell Lung Cancer Journal of Thoracic Oncology. 2: 875-876. PMID 17805068 DOI: 10.1097/Jto.0B013E31811F3A91 |
0.4 |
|
2007 |
Bradley JD, Hope A, El Naqa I, Apte A, Lindsay PE, Bosch W, Matthews J, Sause W, Graham MV, Deasy JO. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. International Journal of Radiation Oncology, Biology, Physics. 69: 985-92. PMID 17689035 DOI: 10.1016/J.Ijrobp.2007.04.077 |
0.543 |
|
2007 |
Bradley J. Radiographic response and clinical toxicity following SBRT for stage I lung cancer. Journal of Thoracic Oncology. 2. PMID 17603307 DOI: 10.1097/Jto.0B013E318074E50C |
0.472 |
|
2007 |
Lindsay PE, El Naqa I, Hope AJ, Vicic M, Cui J, Bradley JD, Deasy JO. Retrospective monte carlo dose calculations with limited beam weight information. Medical Physics. 34: 334-46. PMID 17278519 DOI: 10.1118/1.2400826 |
0.488 |
|
2007 |
Biehl KJ, Bradley J. Reply: 18F-FDG PET in Planning Radiation Treatment of Non–Small Cell Lung Cancer: Where Exactly Is the Tumor? The Journal of Nuclear Medicine. 48: 1403-1403. DOI: 10.2967/Jnumed.107.041459 |
0.41 |
|
2007 |
Komaki R, Moughan J, Ettinger D, Videtic G, Bradley J, Glisson B, Choy H. Toxicities in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent chemotherapy for limited small cell lung cancer (LSCLC) (RTOG 0239) Journal of Clinical Oncology. 25: 7717-7717. DOI: 10.1200/Jco.2007.25.18_Suppl.7717 |
0.341 |
|
2007 |
Komaki R, Moughan J, Ettinger D, Videtic G, Bradley J, Glisson B, Choy H. P1-205: Acute esophagitis correlated with irradiated volume in a Phase II Study of Accelerated High Dose Thoracic Radiation Therapy (TRT) with Concurrent Chemotherapy for Limited Small Cell Lung Cancer (LSCLC) (RTOG 0239) Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000284303.40467.9F |
0.459 |
|
2007 |
El Naqa I, Bradley J, Deasy J. Improved Radiation Pneumonitis Risk Modeling Using a Nonlinear Approach International Journal of Radiation Oncology*Biology*Physics. 69: S180-S181. DOI: 10.1016/J.Ijrobp.2007.07.327 |
0.43 |
|
2007 |
Lynch B, Cui J, Yang D, Lu W, Hubenschmidt J, Parikh P, Low D, Bradley J, Dempsey J, Deasy J. Four-Dimensional Dose Calculations to Determine the Effect of Breathing Motion on Outcomes-Related Parameters for Lung Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 69: S132-S133. DOI: 10.1016/J.Ijrobp.2007.07.244 |
0.554 |
|
2007 |
Hope A, Georg M, Yang D, El Naqa I, Lindsay P, Lu W, Pless R, Bradley J, Low D, Deasy J. Incorporating Population-Based Breathing Motion Improves Radiation Pneumonitis Modeling Correlation International Journal of Radiation Oncology*Biology*Physics. 69: S506-S507. DOI: 10.1016/J.Ijrobp.2007.07.1724 |
0.423 |
|
2007 |
Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Choy H. Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 69: S86. DOI: 10.1016/J.IJROBP.2007.07.156 |
0.324 |
|
2006 |
Bradley JD, Nofal AN, El Naqa IM, Lu W, Liu J, Hubenschmidt J, Low DA, Drzymala RE, Khullar D. Comparison of helical, maximum intensity projection (MIP), and averaged intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 81: 264-8. PMID 17113668 DOI: 10.1016/J.Radonc.2006.10.009 |
0.332 |
|
2006 |
El Naqa I, Low DA, Bradley JD, Vicic M, Deasy JO. Deblurring of breathing motion artifacts in thoracic PET images by deconvolution methods. Medical Physics. 33: 3587-600. PMID 17089825 DOI: 10.1118/1.2336500 |
0.408 |
|
2006 |
El Naqa I, Suneja G, Lindsay PE, Hope AJ, Alaly JR, Vicic M, Bradley JD, Apte A, Deasy JO. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. Physics in Medicine and Biology. 51: 5719-35. PMID 17068361 DOI: 10.1088/0031-9155/51/22/001 |
0.461 |
|
2006 |
Hope AJ, Lindsay PE, El Naqa I, Alaly JR, Vicic M, Bradley JD, Deasy JO. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. International Journal of Radiation Oncology, Biology, Physics. 65: 112-24. PMID 16618575 DOI: 10.1016/J.Ijrobp.2005.11.046 |
0.437 |
|
2006 |
El Naqa I, Bradley J, Blanco AI, Lindsay PE, Vicic M, Hope A, Deasy JO. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. International Journal of Radiation Oncology, Biology, Physics. 64: 1275-86. PMID 16504765 DOI: 10.1016/J.Ijrobp.2005.11.022 |
0.504 |
|
2006 |
Clark V, El Naqa I, Hope A, Suneja G, Bradley J, Deasy J. TH-E-230A-01: Can Dose-Volume Parameters Be Replaced with GEUD in the Treatment Planning Process? Medical Physics. 33: 2294-2294. DOI: 10.1118/1.2241963 |
0.461 |
|
2006 |
El Naqa I, Bae K, Zheng J, Khullar D, Bradley J, Grigsby P, Low D, Deasy J. TU-C-ValA-03: Concurrent Multimodality Image Segmentation Medical Physics. 33: 2186-2186. DOI: 10.1118/1.2241508 |
0.474 |
|
2006 |
Low D, Lu W, Parikh P, Hubenschmidt J, Mutic S, Bradley J. MO-D-ValA-01: Modeling & Characterization of Respiratory Motion Medical Physics. 33: 2163-2163. DOI: 10.1118/1.2241424 |
0.357 |
|
2006 |
Deasy J, El Naqa I, Hope A, Lindsay P, Sause W, Graham M, Bosch W, Matthews J, Bradley J. 110 International Journal of Radiation Oncology*Biology*Physics. 66: S62-S63. DOI: 10.1016/J.Ijrobp.2006.07.141 |
0.371 |
|
2006 |
Naqa IE, Clark VH, Chen Y, Vicic M, Khullar D, Shimpi S, Hope A, Bradley J, Deasy JO. 2847: Treatment Outcome-based Objective Functions for IMRT Treatment Planning International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.1266 |
0.363 |
|
2005 |
Goodgame B, Viswanathan A, Pillot G, Gao F, Morgensztern D, Bradley J, Guthrie T, Battafarano R, Govindan R. Outcomes in 708 resected stage I non-small cell lung cancer (NSCLC) subjects and a prognostic index for relapse. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7198. PMID 27945012 DOI: 10.1200/Jco.2005.23.16_Suppl.7198 |
0.374 |
|
2005 |
Krupnick AS, Kreisel D, Hope A, Bradley J, Govindan R, Meyers B. Recent advances and future perspectives in the management of lung cancer. Current Problems in Surgery. 42: 540-610. PMID 16087000 DOI: 10.1067/J.Cpsurg.2005.05.002 |
0.368 |
|
2005 |
Bradley J. A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group. Seminars in Oncology. 32: 111-113. PMID 16015546 DOI: 10.1053/J.Seminoncol.2005.03.020 |
0.463 |
|
2005 |
Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3480-7. PMID 15908657 DOI: 10.1200/JCO.2005.12.120 |
0.308 |
|
2005 |
Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. International Journal of Radiation Oncology, Biology, Physics. 61: 318-28. PMID 15667949 DOI: 10.1016/j.ijrobp.2004.06.260 |
0.343 |
|
2005 |
Lindsay P, El Naqa I, Hope A, Bradley J, Vicic M, Deasy J. TU-FF-A1-06: Monte Carlo Based Retrospective Dose Calculations for Outcomes Modeling Medical Physics. 32: 2114-2114. DOI: 10.1118/1.1998471 |
0.476 |
|
2005 |
Low D, Parikh P, Laforest R, Dempsey J, Lu W, Mutic S, Hubenschmidt J, Nystrom M, Miller T, Grigsby P, Bradley J. TU-D-J-6C-07: A Method for Acquiring PET Images Without Breathing Motion Artifacts Medical Physics. 32: 2095-2096. DOI: 10.1118/1.1998398 |
0.315 |
|
2005 |
Hope A, Alaly J, Liu J, Deasy J, Bradley J, Drzymala R. TU-C-T-617-06: Importance of Pre-Fraction Helical CT Isocenter Verification in Extracranial Stereotactic Radiosurgery Medical Physics. 32: 2087-2087. DOI: 10.1118/1.1998364 |
0.422 |
|
2005 |
El Naqa I, Low D, Bradley J, Vicic M, Deasy J. TU-C-J-6B-04: Deblurring of Breathing Motion Artifacts in Thoracic PET Images Medical Physics. 32: 2082-2083. DOI: 10.1118/1.1998348 |
0.401 |
|
2005 |
El Naqa I, Clark V, Bradley J, Deasy J. SU-FF-T-375: Machine Learning Methods for Radiobiological Outcomes Modeling Medical Physics. 32: 2037-2037. DOI: 10.1118/1.1998104 |
0.412 |
|
2005 |
Werner-Wasik M, Swann S, Bradley J, Graham M, Emami B, Purdy J, Sause W. PD-121 Increasing tumor volume is predictive of poor overall- andprogression free survival: Secondary analysis of the Radiation Therapy Oncology Group (RTOG) 93-11 Phase I–II radiation dose escalation study in patients with inoperable non-small cell lung cancer (NSCLC) Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80454-4 |
0.478 |
|
2005 |
Deasy J, El Naqa I, Lindsay P, Alaly J, Bradley J, Hope A. 246 Outcomes modeling based on 3-D images and dose-volume data Radiotherapy and Oncology. 76: S118. DOI: 10.1016/S0167-8140(05)81223-X |
0.415 |
|
2005 |
Lindsay P, El Naqa I, Hope A, Bradley J, Vicic M, Deasy J. Modeling of Pneumonitis Risk using Monte Carlo Corrected Dosimetry International Journal of Radiation Oncology*Biology*Physics. 63: S557. DOI: 10.1016/J.Ijrobp.2005.07.938 |
0.372 |
|
2005 |
Hope A, Lindsay P, El Naqa I, Bradley J, Vivic M, Deasy J. Clinical, Dosimetric, and Location-Related Factors to Predict Local Control in Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 63: S231. DOI: 10.1016/J.Ijrobp.2005.07.394 |
0.493 |
|
2005 |
Bradley J, Deasy J, El Naqa I, Lindsay P, Hope A, Bosch W, Matthews J, Sause W, Graham M. Predictors of Lung Toxicity from the RTOG 9311 Radiation Dose Escalation Trial: GTV Position is Important International Journal of Radiation Oncology*Biology*Physics. 63: S40-S41. DOI: 10.1016/J.Ijrobp.2005.07.073 |
0.523 |
|
2004 |
Bradley J, Movsas B. Radiation esophagitis: Predictive factors and preventive strategies. Seminars in Radiation Oncology. 14: 280-286. PMID 15558501 DOI: 10.1016/J.Semradonc.2004.06.003 |
0.403 |
|
2004 |
Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 59: 78-86. PMID 15093902 DOI: 10.1016/J.Ijrobp.2003.10.044 |
0.413 |
|
2004 |
Bradley J, Deasy JO, Bentzen S, El-Naqa I. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. International Journal of Radiation Oncology, Biology, Physics. 58: 1106-13. PMID 15001251 DOI: 10.1016/J.Ijrobp.2003.09.080 |
0.56 |
|
2004 |
Bradley JD, Perez CA, Dehdashti F, Siegel BA. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 96S-101S. PMID 14736840 |
0.326 |
|
2004 |
El Naqa IM, Low DA, Christensen G, Parikh PJ, Song JH, Nystrom MM, Lu W, Deasy JO, Hubenschmidt JP, Wahab SH, Mutic S, Singh AK, Bradley JD. Automated 4-D lung computed tomography reconstruction during free breathing for conformal radiation therapy Proceedings of Spie - the International Society For Optical Engineering. 5369: 100-106. DOI: 10.1117/12.536141 |
0.47 |
|
2004 |
Hope A, El Naqa I, Bradley J, Vivic M, Lindsay P, Bosch W, Purdy J, Deasy J. Radiation pneumonitis/fibrosis risk based on dosimetric, clinical, and location-related factors International Journal of Radiation Oncology*Biology*Physics. 60: S204. DOI: 10.1016/J.Ijrobp.2004.06.150 |
0.444 |
|
2003 |
Low DA, Nystrom M, Kalinin E, Parikh P, Dempsey JF, Bradley JD, Mutic S, Wahab SH, Islam T, Christensen G, Politte DG, Whiting BR. A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing. Medical Physics. 30: 1254-63. PMID 12852551 DOI: 10.1118/1.1576230 |
0.31 |
|
2003 |
Bradley JD, Wahab S, Lockett MA, Perez CA, Purdy JA. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. International Journal of Radiation Oncology, Biology, Physics. 56: 342-7. PMID 12738307 DOI: 10.1016/S0360-3016(02)04614-X |
0.315 |
|
2003 |
Dehdashti F, Mintun MA, Lewis JS, Bradley J, Govindan R, Laforest R, Welch MJ, Siegel BA. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. European Journal of Nuclear Medicine and Molecular Imaging. 30: 844-50. PMID 12692685 DOI: 10.1007/S00259-003-1130-4 |
0.312 |
|
2003 |
Singh AK, Lockett MA, Bradley JD. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 55: 337-41. PMID 12527046 DOI: 10.1016/S0360-3016(02)03937-8 |
0.378 |
|
2003 |
Deasy J, Bradley J, El Naqa I, Bosch W, Vicic M, Purdy J. Risk of radiation pneumonitis classified via dosimetric parameters International Journal of Radiation Oncology*Biology*Physics. 57: S412. DOI: 10.1016/S0360-3016(03)01352-X |
0.432 |
|
2003 |
Bradley J, Graham M, Winter K, Purdy J, Komaki R, Roa W, Ryu J, Bosch W, Emami B. Acute and late toxicity results of RTOG 9311: a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer International Journal of Radiation Oncology*Biology*Physics. 57: S137-S138. DOI: 10.1016/S0360-3016(03)00846-0 |
0.363 |
|
2002 |
Kong FM, Klein EE, Bradley JD, Mansur DB, Taylor ME, Perez CA, Myerson RJ, Harms WB. The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation. International Journal of Radiation Oncology, Biology, Physics. 54: 963-71. PMID 12377351 DOI: 10.1016/S0360-3016(02)03741-0 |
0.306 |
|
2002 |
Bradley JD, Scott CB, Paris KJ, Demas WF, Machtay M, Komaki R, Movsas B, Rubin P, Sause WT. A phase III comparison of radiation therapy with or without recombinant β-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04) International Journal of Radiation Oncology Biology Physics. 52: 1173-1179. PMID 11955727 DOI: 10.1016/S0360-3016(01)02797-3 |
0.317 |
|
2002 |
Bradley JD, Ieumwananonthachai N, Purdy JA, Wasserman TH, Lockett MA, Graham MV, Perez CA. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. International Journal of Radiation Oncology, Biology, Physics. 52: 49-57. PMID 11777621 DOI: 10.1016/S0360-3016(01)01772-2 |
0.375 |
|
2002 |
Low D, Bradley J, Dempsey J, Politte D, Islam K, Mutic S, Deasy J, Zakarian C, Christensen G. A method for the four-dimensional measurement of normal and cancerous lung during free breathing International Journal of Radiation Oncology*Biology*Physics. 54: 199-200. DOI: 10.1016/S0360-3016(02)03401-6 |
0.466 |
|
2002 |
Bradley J, Deasy J, Bentzen S, Bosch W, Purdy J. Irradiated esophageal surface area predicts for esophagitis in patients treated for non-small cell carcinoma of the lung International Journal of Radiation Oncology*Biology*Physics. 54: 105-106. DOI: 10.1016/S0360-3016(02)03238-8 |
0.473 |
|
2001 |
Singh A, Lockett M, Bradley J. Analysis of clinical and dosimetric predictors of radiation-induced esophageal toxicity in patients with non-small cell lung cancer treated with three dimensional conformal radiation therapy International Journal of Radiation Oncology*Biology*Physics. 51: 352. DOI: 10.1016/S0360-3016(01)02472-5 |
0.368 |
|
2001 |
Low D, Bradley J, Deasy J, Laforest R, Parikh P, Sohn J, Hibbard L, Dehdashti F, Mutic S, Bosch W. Lung trajectory mapping International Journal of Radiation Oncology*Biology*Physics. 51: 208-209. DOI: 10.1016/S0360-3016(01)02206-4 |
0.419 |
|
2001 |
Graham M, Winter K, Purdy J, Bradley J, Komaki R, Roa W, Ryu J, Harms W, Emami B. Preliminary results of a radiation therapy oncology group trial (RTOG 9311), a dose escalation study using 3d conformal radiation therapy in patients with inoperable nonsmall cell lung cancer International Journal of Radiation Oncology*Biology*Physics. 51: 19-20. DOI: 10.1016/S0360-3016(01)01858-2 |
0.351 |
|
2000 |
Bradley J, Deasy J, Purdy J, Wasserman T, Graham M, Ieumwananonthachai N, Lockett M. Gross tumor volume is an independent predictor of survival in non-small cell lung carcinoma patients treated with conformal radiotherapy International Journal of Radiation Oncology*Biology*Physics. 48: 129-130. DOI: 10.1016/S0360-3016(00)80055-3 |
0.491 |
|
Show low-probability matches. |